Rocca W A, Hofman A, Brayne C, Breteler M M, Clarke M, Copeland J R, Dartigues J F, Engedal K, Hagnell O, Heeren T J
Centro SMID, Firenze, Italy.
Ann Neurol. 1991 Sep;30(3):381-90. doi: 10.1002/ana.410300310.
We reanalyzed and compared current prevalence estimates of Alzheimer's disease in Europe. Studies characterized as follows qualified for comparison: dementia defined by the Diagnostic and Statistical Manual for Mental Disorders, 3rd edition, or equivalent criteria; Alzheimer's disease diagnosed by the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association or equivalent criteria; case-finding through direct individual examination; appropriate sample size; and inclusion of institutionalized persons. Of the 23 European surveys of dementia considered, six fulfilled the inclusion criteria. When age and sex were considered, there were no major geographic differences in the prevalence of Alzheimer's disease across Europe. Overall European prevalence (per 100 population) for the age groups 30 to 59, 60 to 69, 70 to 79, and 80 to 89 years was, respectively, 0.02, 0.3, 3.2, and 10.8. Prevalence increased exponentially with advancing age and, in some populations, was consistently higher in women. Prevalence remained stable over 15 years in one study.
我们重新分析并比较了欧洲目前对阿尔茨海默病患病率的估计。符合以下特征的研究可用于比较:根据《精神疾病诊断与统计手册》第三版或等效标准定义的痴呆症;由美国国立神经疾病与中风研究所 - 阿尔茨海默病及相关疾病协会或等效标准诊断的阿尔茨海默病;通过直接个体检查进行病例发现;适当的样本量;以及纳入机构化人员。在纳入考虑的23项欧洲痴呆症调查中,有6项符合纳入标准。当考虑年龄和性别时,欧洲各地阿尔茨海默病的患病率没有重大地理差异。欧洲30至59岁、60至69岁、70至79岁和80至89岁年龄组的总体患病率(每100人)分别为0.02、0.3、3.2和10.8。患病率随年龄增长呈指数上升,并且在一些人群中,女性患病率始终较高。在一项研究中,患病率在15年内保持稳定。